Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Cipher Pharmaceuticals
Cipher Pharmaceuticals
(CPHR)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Conzip
Tramadol
2010-05-07
2030-2040
Pain
,
Fever
,
Ankylosing spondylitis
,
Rheumatoid arthritis
,
Osteoarthritis
,
Adenomatous polyposis coli
,
Dysmenorrhea
Lipofen
Fenofibrate
2006-01-11
2024-2033
Hypercholesterolemia
,
Coronary artery disease
,
Dyslipidemias
,
Hypertriglyceridemia
,
Hyperlipoproteinemias
,
Periodontal diseases
,
Infectious skin diseases
,
Gram-negative bacterial infections
,
Oral candidiasis
,
Gram-positive bacterial infections
Natroba
Spinosad
2011-01-18
2023-2033
Lice infestations
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Tramadol
healthy volunteers/patients
Spinosad
scabies
Nepidermin
actinic keratosis
,
keratosis
,
carcinoma
,
basal cell carcinoma
,
basal cell neoplasms
Trinessa
infections
,
hiv infections
,
acquired immunodeficiency syndrome
,
asthma
,
bacterial infections
,
type 2 diabetes mellitus
,
renal cell carcinoma
,
human influenza
,
healthy volunteers/patients
,
anemia
,
respiratory tract infections
,
acute coronary syndrome
,
embryo transfer
,
vivax malaria
,
premature obstetric labor
,
vomiting
,
nausea
,
alzheimer disease
,
diabetes mellitus
,
atrial fibrillation
,
atherosclerosis
,
tuberculosis
,
pulmonary tuberculosis
,
lung diseases
,
chronic obstructive pulmonary disease
,
obstructive lung diseases
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use